Home / World News / Artrya advises FDA application for Artrya Salix knocked back

Artrya advises FDA application for Artrya Salix knocked back

Perth-based medical technology Artrya says the US Food and Drug Administration has knocked back its application for commercial use of its Salix Coronary Anatomy product. 

About brandsauthority

Check Also

SpaceX, Tesla, and Boring Company execs are helping Elon Musk at Twitter, records reveal

Elon Musk led a $US44 billion acquisition of Twitter and appointed himself CEO there in …

%d bloggers like this: